Tumour-infiltrating CD4-, CD8- and FOXP3-positive immune cells as predictive markers of mortality in BRCA1- and BRCA2-associated breast cancer-Reference-Cited by-同舟云学术

Tumour-infiltrating CD4-, CD8- and FOXP3-positive immune cells as predictive markers of mortality in BRCA1- and BRCA2-associated breast cancer

Published:2021-08-07 Issue:10 Volume:125 Page:1388-1398
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

Jørgensen Nanna^ORCID,Hviid Thomas Vauvert F.^ORCID,Nielsen Lise B.,Sønderstrup Ida M. H.,Eriksen Jens Ole,Ejlertsen Bent,Gerdes Anne-Marie^ORCID,Kruse Torben A.,Thomassen Mads,Jensen Maj-Britt,Lænkholm Anne-Vibeke

Funder

Region Sjælland

Region of Southern Denmark, Den Forskningsfremmende Pulje i Region Sjælland

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

https://www.nature.com/articles/s41416-021-01514-7.pdf

Reference69 articles.

1. Gerdes AM, Cruger DG, Thomassen M, Kruse TA. Evaluation of two different models to predict BRCA1 and BRCA2 mutations in a cohort of Danish hereditary breast and/or ovarian cancer families. Clin Genet. 2006;69:171–8.

2. Melchor L, Benítez J. The complex genetic landscape of familial breast cancer. Hum Genet. 2013;132:845–63.

3. Armstrong N, Ryder S, Forbes C, Ross J, Quek RGW. A systematic review of the international prevalence of BRCA mutation in breast cancer. Clin Epidemiol. 2019;11:543–61.

4. Graeser MK, Engel C, Rhiem K, Gadzicki D, Bick U, Kast K, et al. Contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers. J Clin Oncol. 2009;27:5887–92.

5. Wooster R, Bignell G, Lancaster J, Swift S, Seal S, Mangion J, et al. Identification of the breast cancer susceptibility gene BRCA2. Nature. 1995;378:789–92.

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Potential of FOXP3 in Predicting Survival and Treatment Response in Breast Cancer;International Journal of General Medicine;2024-03

2. Immune infiltration, aggressive pathology, and poor survival outcomes in RECQL helicase deficient breast cancers;Neoplasia;2024-01

3. Occurrence of Chromosomal Aberrations in the Traffic Police Population in Tiruchirappalli;INT J HUM GENET;2023

4. The DNA Damage Response and Inflammation in Cancer;Cancer Discovery;2023-04-07

5. The prognostic value of tumour-infiltrating lymphocytes, programmed cell death protein-1 and programmed cell death ligand-1 in Stage I–III triple-negative breast cancer;British Journal of Cancer;2023-03-25